Literature DB >> 30468080

Ways to increase adherence to allergen immunotherapy.

Constantinos Pitsios1, Nikolas Dietis1.   

Abstract

Adherence to allergen immunotherapy (AIT) is crucial for its efficacy. Subcutaneous AIT requires monthly visits (or more extended in the case of venom immunotherapy), while sublingual AIT is performed with a daily intake of allergen drops. Non-adherence to an AIT schedule and premature discontinuation are common problems. Various studies have shown controversial results on the rate of AIT adherence. The aim of this review is to describe the problem of non-adherence and to offer some evidence-based advice to allergologists on how to increase it. Better patient education at the beginning of treatment, sharing with patients the decision on which type of immunotherapy to select and showing sincere interest in their treatment concerns are some tips that can help to increase adherence. A well organized allergologist time schedule not only increases safety but also offers the possibility of close follow-up and an increase in patient loyalty.

Entities:  

Keywords:  Allergen immunotherapy; adherence; allergy; compliance

Mesh:

Year:  2018        PMID: 30468080     DOI: 10.1080/03007995.2018.1552044

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  7 in total

Review 1.  ARIA 2019, Allerjik Rinite Tedavi Yaklaşımı-Türkiye.

Authors:  Ayşe Arzu Yorgancıoğlu; Bilun Gemicioğlu; Cemal Cingi; Ömer Kalaycı; Ali Fuat Kalyoncu; Claus Bachert; Peter Hellings; Oliver Pfaar; Holger J Schünemann; Dana Wallace; Anna Bedbrook; Wienczyslawa Czarlewski; Jean Bousquet
Journal:  Turk Thorac J       Date:  2020-03-01

Review 2.  ARIA 2019 Care Pathways for Allergic Rhinitis in the Kuwait Health Care System.

Authors:  Mona Al-Ahmad; Jasmina Nurkic; Claus Bachert; Oliver Pfaar; Holger J Schunemann; Wienczyslawa Czarlewski; Anna Bedbrook; Jean Bosquet
Journal:  Med Princ Pract       Date:  2020-10-23       Impact factor: 1.927

Review 3.  Patient's Adherence and Compliance and Quality of Life During/After VIT.

Authors:  Cristoforo Incorvaia; Enrico Heffler; Silvia Peveri; Francesco Pucciarini; Giorgio Walter Canonica; Erminia Ridolo
Journal:  Front Allergy       Date:  2022-06-28

Review 4.  Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures.

Authors:  Constantinos Pitsios
Journal:  J Asthma Allergy       Date:  2021-02-18

Review 5.  Current treatment strategies for seasonal allergic rhinitis: where are we heading?

Authors:  Erminia Ridolo; Cristoforo Incorvaia; Francesco Pucciarini; Elena Makri; Giovanni Paoletti; Giorgio Walter Canonica
Journal:  Clin Mol Allergy       Date:  2022-08-10

Review 6.  Contraindications to immunotherapy: a global approach.

Authors:  C Pitsios; M Tsoumani; M B Bilò; G J Sturm; P Rodríguez Del Río; R Gawlik; F Ruëff; G Paraskevopoulos; E Valovirta; O Pfaar; M A Calderón; P Demoly
Journal:  Clin Transl Allergy       Date:  2019-09-11       Impact factor: 5.871

7.  Establishment and Benefits of a Normal Pressure Hydrocephalus Support Group on Patient Education and Experience.

Authors:  Peter Tran; Christopher Q Nguyen; Melissa Huang; Judy Pham; Catthi Ly; Ishan Shah; Ronald Sahyouni; Cassie Poole; Kieu Tran; Jefferson W Chen
Journal:  Cureus       Date:  2019-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.